Lincoln Alternative Strategies LLC Reports 9.9% Ownership in XORTX Therapeutics Inc.

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, reporting beneficial ownership of 572,470 common shares of XORTX Therapeutics Inc., representing 9.9% of the outstanding shares. The filing indicates that the shares were not acquired for the purpose of influencing the control of the issuer. Lincoln Alternative Strategies LLC has sole voting and dispositive power over these shares. The filing was made under Rule 13d-1(c) and includes a certification that the shares were not acquired to influence control or as part of a transaction with that purpose.